StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research note issued to investors on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Trading Down 0.9 % NASDAQ:XBIT opened at $4.46 on Wednesday. XBiotech has a 1 year low of $3.00 and a 1 year high […]
Related Keywords
Switzerland , Swiss , , Blackrock Inc , Geode Capital Management , Swiss National Bank , Pricet Rowe Associates Inc , Nasdaq , Xbiotech Inc , Free Report , Trading Down , Capital Management , National Bank , Get Free Report , True Human , Xbiotech , Nasdaq Xbit , Taxbit , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.